BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22033984)

  • 1. Inhibitory effects of IL-6 on IGF-1 activity in skeletal myoblasts could be mediated by the activation of SOCS-3.
    Al-Shanti N; Stewart CE
    J Cell Biochem; 2012 Mar; 113(3):923-33. PubMed ID: 22033984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts--potential cross-talk with IGF system.
    Al-Shanti N; Saini A; Faulkner SH; Stewart CE
    Growth Factors; 2008 Apr; 26(2):61-73. PubMed ID: 18428025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells.
    Venieratos PD; Drossopoulou GI; Kapodistria KD; Tsilibary EC; Kitsiou PV
    Cell Signal; 2010 May; 22(5):791-800. PubMed ID: 20067833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-1 (IGF-1) promotes myoblast proliferation and skeletal muscle growth of embryonic chickens via the PI3K/Akt signalling pathway.
    Yu M; Wang H; Xu Y; Yu D; Li D; Liu X; Du W
    Cell Biol Int; 2015 Aug; 39(8):910-22. PubMed ID: 25808997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts.
    Broussard SR; McCusker RH; Novakofski JE; Strle K; Shen WH; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2003 Jul; 144(7):2988-96. PubMed ID: 12810554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol.
    Saini A; Al-Shanti N; Sharples AP; Stewart CE
    Exp Physiol; 2012 Mar; 97(3):400-18. PubMed ID: 22125309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation.
    Tiffin N; Adi S; Stokoe D; Wu NY; Rosenthal SM
    Endocrinology; 2004 Nov; 145(11):4991-6. PubMed ID: 15489316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.
    Quinn LS; Anderson BG; Plymate SR
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1538-51. PubMed ID: 17940216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells.
    Sadowski CL; Wheeler TT; Wang LH; Sadowski HB
    Endocrinology; 2001 Sep; 142(9):3890-900. PubMed ID: 11517167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide.
    Strle K; Broussard SR; McCusker RH; Shen WH; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Endocrinology; 2004 Oct; 145(10):4592-602. PubMed ID: 15256490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of cytokine signaling 1 suppresses muscle differentiation through modulation of IGF-I receptor signal transduction.
    Inaba M; Saito H; Fujimoto M; Sumitani S; Ohkawara T; Tanaka T; Kouhara H; Kasayama S; Kawase I; Kishimoto T; Naka T
    Biochem Biophys Res Commun; 2005 Mar; 328(4):953-61. PubMed ID: 15707970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and the insulin-like growth factor system in myogenesis.
    Florini JR; Ewton DZ; Coolican SA
    Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation.
    Adi S; Bin-Abbas B; Wu NY; Rosenthal SM
    Endocrinology; 2002 Feb; 143(2):511-6. PubMed ID: 11796505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-1 attenuates LPS induced pro-inflammatory cytokines expression in buffalo (Bubalus bubalis) granulosa cells.
    Onnureddy K; Ravinder ; Onteru SK; Singh D
    Mol Immunol; 2015 Mar; 64(1):136-43. PubMed ID: 25433435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro- and anti-apoptotic roles for IGF-I in TNF-alpha-induced apoptosis: a MAP kinase mediated mechanism.
    Saini A; Al-Shanti N; Faulkner SH; Stewart CE
    Growth Factors; 2008 Oct; 26(5):239-53. PubMed ID: 18651291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
    McDaneld TG; Spurlock DM
    J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 affects pacsin3, ephrinA4 expression and cytoskeletal proteins in differentiating primary skeletal myoblasts through transcriptional and post-transcriptional mechanisms.
    Milewska M; Domoradzki T; Majewska A; Błaszczyk M; Gajewska M; Hulanicka M; Grzelkowska-Kowalczyk K
    Cell Tissue Res; 2020 Apr; 380(1):155-172. PubMed ID: 31820147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha.
    Foulstone EJ; Huser C; Crown AL; Holly JM; Stewart CE
    Exp Cell Res; 2004 Mar; 294(1):223-35. PubMed ID: 14980516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling.
    Varma H; Conrad SE
    Cancer Res; 2002 Jul; 62(14):3985-91. PubMed ID: 12124331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.